The QOL Impact of Lymphedema After Breast Cancer

News
Video

Lymphedema is a common adverse effect and may negatively impact a patient’s body image.

Steven Chen, MD, MBA, discussed the physiological and physical impacts commonly associated with lymphedema after a breast cancer diagnosis.

Chen, breast surgeon and chief medical officer at Impedimed, discussed how lymphedema can lead to the constant reminder that patients have breast cancer because it’s so visible. Specifically, those who are undergoing mastectomy or reconstruction and dealing with those physical changes.

He also touched upon ways to identify lymphedema and tools to help with that. Even if clinicians or patients don’t have access to these higher-end tools, a measuring tape can be used to keep track of the lymphedema.

Transcript:

I think of lymphedema as having 2 different sets of impacts. One is the psychological [impact]. Once [patients] have lymphedema it’s a reminder that they had breast cancer and because some [patients] live with the most permanent visible, reminder that they had breast cancer, every time they look at their arm, and their clothes don’t fit right. Body image is a big issue for patients with breast cancer already and then [they] have a visible [characteristic] beyond what’s underneath their shirt. To have something visible is very distressing for patients psychologically and physically. We worry about skin changes; they may get dry skin and even some [patients] talk about having increased amounts of skin cancer. If you have chronic lymphedema, you can get a higher rate of infection.

I think the biggest take-home message that I would have is that we now have data that show that early intervention on subclinical pre-symptomatic lymphedema can stop the progression of lymphedema. Knowing this makes it much more important for clinicians to try to find those patients who have early lymphedema and not be so fatalistic about it. Part of catching it early is measuring it. I think the SOZO device is a great way to measure it. If you don’t have access to a SOZA device, which is becoming more common, at least use a tape measure. I would also say that the [National Comprehensive Cancer Network] guidelines, which are commonly used across a number of cancer centers, now specify in the survivorship guidelines that you should be measuring people who are at risk for lymphedema.

Reference

NCCN Clinical Practice Guidelines in Oncology. Breast cancer and survivorship, V.3.2020. Accessed March 21, 2024. https://shorturl.at/CFMSZ

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.